کد مقاله کد نشریه سال انتشار مقاله انگلیسی نسخه تمام متن
2136075 1401595 2016 7 صفحه PDF دانلود رایگان
عنوان انگلیسی مقاله ISI
Hypoxia-induced autophagy as an additional mechanism in human osteosarcoma radioresistance
ترجمه فارسی عنوان
اتوفاژی ناشی از هیپوکسی به عنوان یک مکانیزم اضافی در مقاومت رادیویی استئوسارکوم انسانی
کلمات کلیدی
گونه های اکسیژن فعال. سیستم عامل، استئوسارکوم؛ هیپوکسی؛ اتوفاژی؛ HIF ؛ عامل هیپوکسی
موضوعات مرتبط
علوم زیستی و بیوفناوری بیوشیمی، ژنتیک و زیست شناسی مولکولی تحقیقات سرطان
چکیده انگلیسی

Osteosarcoma (OS) responds poorly to radiotherapy, but the mechanism is unclear. We found OS tumor tissues expressed high level of protein HIF-1α, a common biological marker indicative of hypoxia. It is known that hypoxic cells are generally radioresistant because of reduced production of irradiation-induced DNA-damaging reactive oxygen species (ROS) in the anaerobic condition. Here we report another mechanism how hypoxia induces radioresistance. In MG-63 human osteosarcoma cells, hypoxic pretreatment increased the cellular survival in irradiation. These hypoxia-exposed cells displayed compartmental recruitment of GFP-tagged LC3 and expression of protein LC3-II, and restored the radiosensitivity upon autophagy inhibition. The following immunohistochemistry of OS tumor tissue sections revealed upregulated LC3 expression in a correlation with HIF-1α protein level, implying the possibly causative link between hypoxia and autophagy. Further studies in MG-63 cells demonstrated hypoxic pretreatment reduced cellular and mitochondrial ROS production during irradiation, while inhibition of autophagy re-elicited them. Taken together, our study suggests hypoxia can confer cells resistance to irradiation through activated autophagy to accelerate the clearance of cellular ROS products. This might exist in human osteosarcoma as an additional mechanism for radioresistance.

ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Journal of Bone Oncology - Volume 5, Issue 2, June 2016, Pages 67–73
نویسندگان
, , , , , , , , ,